ORAMED PHARMACEUTICALS INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
ORAMED PHARMACEUTICALS INC. (ORMP) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$8.85 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2025-03-27
- ORAMED PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$8.85M, a 176.29% decline from fiscal 2023.
- ORAMED PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $11.60M.
- ORAMED PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$11.16M.
- ORAMED PHARMACEUTICALS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was $5.31M, a 85.04% increase from fiscal 2020.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 4 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Domestic 125 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 137 month |
|---|---|---|---|---|---|
| 2024-12-31 | -$8.85M 10-K · filed 2025-03-27 | ||||
| 2023-12-31 | $11.60M 10-K · filed 2025-03-27 | ||||
| 2022-12-31 | -$11.16M 10-K · filed 2024-03-06 | $11.16M 10-K · filed 2023-03-06 | |||
| 2021-12-31 | $3.64M 10-K · filed 2023-03-06 | ||||
| 2021-08-31 | $5.31M 10-K · filed 2023-03-06 | ||||
| 2020-08-31 | $2.87M 10-K · filed 2021-11-24 | ||||
| 2019-08-31 | $2.28M 10-K · filed 2020-11-24 | ||||
| 2018-08-31 | $1.93M 10-K · filed 2019-11-27 | ||||
| 2017-08-31 | $1.11M 10-K · filed 2019-11-27 | ||||
| 2016-08-31 | $959.00K 10-K · filed 2018-11-28 | ||||
| 2015-08-31 | $1.23M 10-K · filed 2017-11-29 | ||||
| 2014-08-31 | $893.00K 10-K · filed 2016-11-25 | -$893.00K 10-K · filed 2014-11-14 | |||
| 2013-08-31 | $1.19M 10-K · filed 2015-11-25 | -$1.19M 10-K · filed 2013-11-27 | -$9.63M 10-K · filed 2013-11-27 | ||
| 2012-08-31 | -$599.00K 10-K · filed 2014-11-14 | -$599.07K 10-K · filed 2012-12-12 | -$8.44M 10-K · filed 2012-12-12 | ||
| 2011-08-31 | -$415.84K 10-K · filed 2012-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |